The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human α-Synuclein
Open accessAbstract
Accumulation of α-synuclein in brain is a hallmark of synucleinopathies, neurodegenerative diseases that include Parkinson's disease. Mice overexpressing α-synuclein under the Thy-1 promoter (ASO) show abnormal accumulation of α-synuclein in cortical and subcortical regions of the brain, including the substantia nigra. We examined the motor deficits in ASO mice with a battery of sensorimotor tests that are sensitive to alterations in the nigrostriatal dopaminergic system. Male wild-type and ASO mice were tested every 2 months for 8 months for motor performance and coordination on a challenging beam, inverted grid, and pole, sensorimotor deficits in an adhesive removal test, spontaneous activity in a cylinder, and gait. Fine motor skills were assessed by the ability to grasp cotton from a bin. ASO mice displayed significant impairments in motor performance and coordination and a reduction in spontaneous activity as early as 2 months of age. Motor performance and coordination impairments became progressively worse with age and sensorimotor deficits appeared at 6 months. Fine motor skills were altered at 4 months and worsened at 8 months. These data indicate that overexpression of α-synuclein induced an early and progressive behavioral phenotype that can be detected in multiple tests of sensorimotor function. These behavioral deficits provide a useful way to assess novel drug therapy in genetic models of synucleinopathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Self-citationAtm-Deficient Mice: A Paradigm of Ataxia Telangiectasia
Barlow, C., Hirotsune, S., Paylor, R., Liyanage, M., Eckhaus, M., Collins, F., Shiloh, Y., Crawley, J. N., Ried, T., Tagle, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)80086-0 · Cited by 1,458
Schallert, T., Fleming, S. M., Leasure, J. L., Tillerson, J. L., & Bland, S. T. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00005-8 · Cited by 1,354
Self-citationCarter, R. J., Lione, L. A., Humby, T., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., & Morton, A. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-08-03248.1999 · Cited by 947
(2000) · Cited by 919
Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons
Goldberg, M. S., Fleming, S. M., Palacino, J. J., Cepeda, C., Lam, H. A., Bhatnagar, A., Meloni, E. G., Wu, N., Ackerson, L. C., Klapstein, G. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308947200 · Cited by 913
Self-citationA Role for α-Synuclein in the Regulation of Dopamine Biosynthesis
Perez, R. G., Waymire, J. C., Lin, E., Liu, J. J., Guo, F., & Zigmond, M. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03090.2002 · Cited by 598 · cited 1×
“Furthermore, in vitro evidence links -synuclein overexpression to alterations in DA release and synthesis (Lotharius and Brundin, 2002; Lotharius et al., 2002; Perez et al., 2002).”
BackgroundMenalled, L. B., Sison, J. D., Dragatsis, I., Zeitlin, S., & Chesselet, M. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10776 · Cited by 536
Self-citationNeuropathology in mice expressing human alpha-synuclein
van der Putten, H., Wiederhold, K., Probst, A., Barbieri, S., Mistl, C., Danner, S., Kauffmann, S., Hofele, K., Spooren, W. P. J. M., Rüegg, M. A., et al. (2000) · PubMed · doi:10.5451/unibas-ep2767 · Cited by 505
Rockenstein, E., Mallory, M., Hashimoto, M., Song, D., Shults, C. W., Lang, I., & Masliah, E. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10231 · Cited by 502
Self-citationNeuropathology in Mice Expressing Human α-Synuclein
van der Putten, H., Wiederhold, K.-H., Probst, A., Barbieri, S., Mistl, C., Danner, S., Kauffmann, S., Hofele, K., Spooren, W. P. J. M., Ruegg, M. A., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06021.2000 · Cited by 477
Behavioral phenotyping of the MPTP mouse model of Parkinson's disease
Sedelis, M., Schwarting, R. K. W., & Huston, J. P. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00309-6 · Cited by 432
Matsuura, K., Kabuto, H., Makino, H., & Ogawa, N. (1997) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(96)02211-x · Cited by 422
Sensory Neglect Produced by Lateral Hypothalamic Damage
Marshall, J. F., Turner, B. H., & Teitelbaum, P. (1971) · Science · doi:10.1126/science.174.4008.523 · Cited by 405
Forced Limb-Use Effects on the Behavioral and Neurochemical Effects of 6-Hydroxydopamine
Tillerson, J. L., Cohen, A. D., Philhower, J., Miller, G. W., Zigmond, M. J., & Schallert, T. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04427.2001 · Cited by 357
Dopamine Production in the Caudate Putamen Restores Feeding in Dopamine-Deficient Mice
Szczypka, M. S., Kwok, K., Brot, M. D., Marck, B. T., Matsumoto, A. M., Donahue, B. A., & Palmiter, R. D. (2001) · Neuron · doi:10.1016/s0896-6273(01)00319-1 · Cited by 354 · cited 2×
“Both male and female mice shred material to build nests, and analysis of shredding behavior has been used to assess nigrostriatal sensorimotor function in rodents (Upchurch and Schallert, 1983; Sedelis et al., 2000; Hofele et al., 2001; Szczypka et al., 2001).”
BackgroundEffect of Mutant α-Synuclein on Dopamine Homeostasis in a New Human Mesencephalic Cell Line
Lotharius, J., Barg, S., Wiekop, P., Lundberg, C., Raymon, H. K., & Brundin, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205518200 · Cited by 352
A simple quantitative bradykinesia test in MPTP-treated mice.
Ogawa, N., Hirose, Y., Ohara, S., Ono, T., & Watanabe, Y. (1985) · PubMed · Cited by 334
Schallert, T., Upchurch, M., Lobaugh, N., Farrar, S. B., Spirduso, W. W., Gilliam, P., Vaughn, D., & Wilcox, R. E. (1982) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(82)90452-x · Cited by 326
Mouse models of Huntington's disease
Menalled, L. B., & Chesselet, M.-F. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01884-8 · Cited by 315
Self-citationSong, D. D., Shults, C. W., Sisk, A., Rockenstein, E., & Masliah, E. (2004) · Experimental Neurology · doi:10.1016/s0014-4886(03)00342-x · Cited by 295
Self-citationBehavioral and Neurochemical Effects of Wild-Type and Mutated Human α-Synuclein in Transgenic Mice
Richfield, E. K., Thiruchelvam, M. J., Cory-Slechta, D. A., Wuertzer, C., Gainetdinov, R. R., Caron, M. G., Di Monte, D. A., & Federoff, H. J. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7882 · Cited by 285 · cited 1×
“months of age (Masliah et al., 2000; Richfield et al., 2002), except”
Lotharius, J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2395 · Cited by 269
Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice
Hwang, D. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00162-1 · Cited by 257
Sedelis, M., Hofele, K., Auburger, G. W., Morgan, S., Huston, J. P., & Schwarting, R. K. W. (2000) · Behavior Genetics · doi:10.1023/a:1001958023096 · Cited by 252
Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease
BROOKS, D. (2003) · Experimental Neurology · doi:10.1016/j.expneurol.2003.08.008 · Cited by 233
Menalled, L. B., Sison, J. D., Wu, Y., Olivieri, M., Li, X.-J., Li, H., Zeitlin, S., & Chesselet, M.-F. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-18-08266.2002 · Cited by 219
Self-citationA simple method to measure stride length as an index of nigrostriatal dysfunction in mice
Fernagut, P. O., Diguet, E., Labattu, B., & Tison, F. (2002) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(01)00485-x · Cited by 212
Self-citationAlpha-synuclein and transgenic mouse models
Fernagut, P.-O., & Chesselet, M.-F. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.001 · Cited by 200
Self-citationGispert, S. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00198-2 · Cited by 192
Tillerson, J. L., Caudle, W. M., Reverón, M. E., & Miller, G. W. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.8021 · Cited by 191
Forced Nonuse in Unilateral Parkinsonian Rats Exacerbates Injury
Tillerson, J. L., Cohen, A. D., Caudle, W. M., Zigmond, M. J., Schallert, T., & Miller, G. W. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06790.2002 · Cited by 163
Compulsive, Abnormal Walking Caused by Anticholinergics in Akinetic, 6-Hydroxydopamine-Treated Rats
Schallert, T., Whishaw, I. Q., Ramirez, V. D., & Teitelbaum, P. (1978) · Science · doi:10.1126/science.564552 · Cited by 161
Schallert, T., & Tillerson, J. L. (2000) · Central Nervous System Diseases · doi:10.1007/978-1-59259-691-1_8 · Cited by 159
Posture-independent sensorimotor analysis of inter-hemispheric receptor asymmetries in neostriatum
Schallert, T. J., Upchurch, M. B., Wilcox, R. E., & Vaughn, D. M. (1983) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(83)90019-9 · Cited by 152
Parkinson's Disease and Related α‐Synucleinopathies Are Brain Amyloidoses
Trojanowski, J. Q., & LEE, V. M. ‐. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07468.x · Cited by 150
Tillerson, J. L., & Miller, G. W. (2003) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(02)00360-6 · Cited by 146
Marshall, J. F., & Gotthelf, T. (1979) · Experimental Neurology · doi:10.1016/0014-4886(79)90107-9 · Cited by 136
MPTP-Induced Parkinsonian Model in Mice: Biochemistry, Pharmacology and Behavior
Ogawa, N., Mizukawa, K., Hirose, Y., Kajita, S., Ohara, S., & Watanabe, Y. (2008) · European Neurology · doi:10.1159/000116351 · Cited by 121
RESPONSE TO DIVERGENT SELECTION FOR NESTING BEHAVIOR IN MUS MUSCULUS
Lynch, C. B. (1980) · Genetics · doi:10.1093/genetics/96.3.757 · Cited by 113
When did Ray Kennedy's Parkinson's disease begin?
Lees, A. J. (1992) · Movement Disorders · doi:10.1002/mds.870070203 · Cited by 102
Behavioral Phenotyping of Transgenic and Knockout Mice
Crawley, J. N. (1999) · CRC Press eBooks · doi:10.1201/9780849333644.pt3 · Cited by 99
Fernagut, P., Chalon, S., Diguet, E., Guilloteau, D., Tison, F., & Jaber, M. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00778-9 · Cited by 98
Self-citationEvaluation of Nigrostriatal Dopaminergic Function in Adult +/+ and +/− BDNF Mutant Mice
Dluzen, D. E., Gao, X., Story, G. M., Anderson, L. I., Kučera, J., & Walro, J. M. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7698 · Cited by 91
The next frontier in Parkinson's disease
Langston, J. W., & Koller, W. C. (1991) · Neurology · doi:10.1212/wnl.41.5_suppl_2.5 · Cited by 67
A new motor test sensitive to aging and dopaminergic function
Drucker-Colín, R., & García-Hernández, F. (1991) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(91)90081-a · Cited by 64
Kolb, B. E., & Whishaw, I. Q. (1985) · Behavioral Neuroscience · doi:10.1037//0735-7044.99.4.691 · Cited by 55
Neurophysiology of sensorimotor integration in Parkinson's disease.
Rossini, P. M., Filippi, M. M., & Vernieri, F. (1998) · PubMed · Cited by 46
Schallert, T. J. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb32972.x · Cited by 38
Broida, J. P., & Svare, B. B. (1982) · Physiology & Behavior · doi:10.1016/0031-9384(82)90380-8 · Cited by 34
Early diagnosis in Parkinson's disease.
Przuntek, H. (1992) · PubMed · Cited by 26
Early Detection of Parkinson??s Disease: Implications for Treatment
Paola, R. D., & Uitti, R. J. (1996) · Drugs & Aging · doi:10.2165/00002512-199609030-00002 · Cited by 19
Central Nervous System Diseases
Emerich, D., Dean, R. L., & Sanberg, P. R. (2000) · Contemporary Neuroscience · doi:10.1007/978-1-59259-691-1 · Cited by 3
Cited by
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Self-citationKim, S., Kwon, S.-H., Kam, T.-I., Panicker, N., Karuppagounder, S. S., Lee, S., Lee, J. H., Kim, W. R., Kook, M., Foss, C. A., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.035 · Cited by 1,397
“For instance, the pole test is sensitive to dopaminergic function and others are not (Fleming et al., 2004; Taylor et al., 2010), which is similar to the results reported here.”
BackgroundMethodResultMitochondrial dysfunction and oxidative stress in Parkinson's disease
Subramaniam, S. R., & Chesselet, M.-F. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.04.004 · Cited by 913
Self-citationNakamura, K., Nemani, V. M., Azarbal, F., Skibinski, G., Levy, J. M., Egami, K., Munishkina, L., Zhang, J., Gardner, B., Wakabayashi, J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.213538 · Cited by 596
Self-citationSystemic exosomal siRNA delivery reduced alpha‐synuclein aggregates in brains of transgenic mice
Cooper, J. M., Wiklander, P. B. O., Nordin, J. Z., Al‐Shawi, R., Wood, M. J., Vithlani, M., Schapira, A. H. V., Simons, J. P., El‐Andaloussi, S., & Alvarez‐Erviti, L. (2014) · Movement Disorders · doi:10.1002/mds.25978 · Cited by 507
Metadata
- Authors
- Fleming, S. M., Salcedo, J., Fernagut, P.-O., Rockenstein, E., Masliah, E., Levine, M. S., & Chesselet, M.-F.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2004-10-20
- Volume
- 24
- Issue
- 42
- Pages
- 9434-9440
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2009740169
- Cited by
- 474
- References
- 55
- FWCI
- 6.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.